))
All About ViiV: An Interview with CEO Deborah Waterhouse at CROI 2024
Manage episode 406413843 series 2908395
Content provided by Ben Plumley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ben Plumley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
ViiV Healthcare is the world’s only pharmaceutical company dedicated exclusively to HIV, and in this episode, Ben meets its CEO, Deborah Waterhouse, to explore the company’s approach to HIV R&D and commercial success - as well as the controversies its global access strategy has attracted for its new long acting injectables. Deborah and Ben find they have much in common beyond both being Brits growing up in the 70s and 80s, from being students of the humanities choosing to make careers in health, to their favorite pop music.
https://www.who.int/health-topics/hiv-aids
https://www.cdc.gov/hiv/default.html
#ViiV #pharma #HIV #AIDS #treatment #Prevention #PrEP #dualtherapy #longacting #injectables #globalaccess #globalequity #discrimination #positiveaction #womenleaders #IWD
122 episodes
Share
